The Enterprise Value as of June 2026 (TTM) for Tenax Therapeutics, Inc. (TENX) is 78.67M

According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 78.67M. This represents a change of -75.99% compared to the average of 327.61M of the last 4 quarters.

Tenax Therapeutics, Inc. (TENX) Historical Enterprise Value (quarterly & annually)

How has TENX Enterprise Value performed in the past?

The mean historical Enterprise Value of Tenax Therapeutics, Inc. over the last ten years is 45.32M. The current 78.67M Enterprise Value has changed 17.26% with respect to the historical average. Over the past ten years (40 quarters), TENX's Enterprise Value was at its highest in in the March 2026 quarter at 604.41M. The Enterprise Value was at its lowest in in the September 2024 quarter at -25093363.22.

Tenax Therapeutics, Inc. (TENX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tenax Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenax Therapeutics, Inc. (TENX) Average Enterprise Value

How has TENX Enterprise Value performed in the past?

The current Enterprise Value of Tenax Therapeutics, Inc. (TENX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Tenax Therapeutics, Inc. (TENX) Enterprise Value vs. Peers

How is TENX’s Enterprise Value compared to its peers?

Tenax Therapeutics, Inc.’s Enterprise Value is greater than Verrica Pharmaceuticals Inc. (41.88M), greater than SAB Biotherapeutics, Inc. (17.48M), less than Q32 Bio Inc. (121.73M), greater than AN2 Therapeutics, Inc. (76.40M), greater than Jasper Therapeutics, Inc. (-5949824.00), greater than NextCure, Inc. (-4681544.00), greater than Plus Therapeutics, Inc. (9.83M), greater than Boundless Bio, Inc. (62.48M), greater than Pluri Inc. (50.39M), greater than Minerva Neurosciences, Inc. (63.74M),

Build a custom stock screener for Tenax Therapeutics, Inc. (TENX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenax Therapeutics, Inc. (TENX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.